Select Page

Catalym

Description: Catalym develops immunotherapies targeting a placental factor overexpressed in tumors, harnessing the immune system to fight cancer.
Country: Germany
Based in: Munich, Bayern
Founded: 2016
Funding Stage: Series A/B
Tags: ['Therapeutics']

Categories

Details about how we process your information are available in our Privacy Policy.